Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · IEX Real-Time Price · USD
6.45
-0.40 (-5.84%)
May 24, 2022 3:45 PM EDT - Market closed
Income Statement (Annual)
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 |
|---|---|---|
| Selling, General & Admin | 0.9 | 0.92 |
| Research & Development | 4.69 | 3.7 |
| Operating Expenses | 5.59 | 4.62 |
| Operating Income | -5.59 | -4.62 |
| Interest Expense / Income | 0.01 | 0.01 |
| Other Expense / Income | -0.01 | -0.04 |
| Pretax Income | -5.59 | -4.6 |
| Net Income | -5.59 | -4.6 |
| Net Income Common | -5.59 | -4.6 |
| EBITDA | -5.58 | -4.59 |
| EBIT | -5.58 | -4.59 |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).